Singapore Immunohistochemistry Market Size & Outlook
Singapore immunohistochemistry market, 2018-2030 (US$M)
Related Markets
Singapore immunohistochemistry market highlights
- The Singapore immunohistochemistry market generated a revenue of USD 15.7 million in 2023 and is expected to reach USD 23.7 million by 2030.
- The Singapore market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, antibodies was the largest revenue generating product in 2023.
- Antibodies is the most lucrative product segment registering the fastest growth during the forecast period.
Immunohistochemistry market data book summary
| Market revenue in 2023 | USD 15.7 million |
| Market revenue in 2030 | USD 23.7 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Antibodies |
| Fastest growing segment | Antibodies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibodies, Reagents, Equipment, Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG, Merck KGaA, Danaher Corp, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Abcam PLC, Cell Signaling Technology, Bio SB |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.7% of the global immunohistochemistry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan immunohistochemistry market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 228.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunohistochemistry Market Scope
Immunohistochemistry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore immunohistochemistry market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunohistochemistry market will help companies and investors design strategic landscapes.
Antibodies was the largest segment with a revenue share of 42.04% in 2023. Horizon Databook has segmented the Singapore immunohistochemistry market based on antibodies, reagents, equipment, kits covering the revenue growth of each sub-segment from 2018 to 2030.
As estimated by the UN in 2017, Singapore is home to 1.1 million people over the age of 65, representing 19.5% of the total population. This number is expected to reach 2.63 million by 2050. As per WHO, Singapore is expected to be in the category of an aging society in the next five years.
Thus, rising geriatric population is expected to be a major factor driving market growth in the country. According to NCBI, the prevalence of infectious diseases is also high in Singapore. It has faced the threat of various diseases such as Zika virus, H1N1 virus, and SARS in the country.
As per Ministry of Health Singapore, vector-borne diseases are also highly prevalent in Singapore with 13,085 cases in 2016. In order to promote research, the government of Singapore has formed Singapore Infectious Disease Initiative (SIDI) and National Center for Infectious Diseases..
Reasons to subscribe to Singapore immunohistochemistry market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore immunohistochemistry market databook
-
Our clientele includes a mix of immunohistochemistry market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore immunohistochemistry market , including forecasts for subscribers. This country databook contains high-level insights into Singapore immunohistochemistry market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore immunohistochemistry market size, by product, 2018-2030 (US$M)
Singapore Immunohistochemistry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
